跳至主要内容
临床试验/DRKS00014096
DRKS00014096已完成不适用

Prospective study investigating the incidence of heparin-induced thrombocytopenia in patients treated with mechanical circulatory support - HILA

niversitätsklinikum Tübingen0 个研究点目标入组 41 人开始时间: 2018年2月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
41

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Male and female patients =18 years undergoing treatment with ECC and cardiac support systems (ECMO = extracorporeal membrane oxygenation / / LVAD = left ventricular assist devices) due to cardiac failure, or lung failure, or a combination of these diseases.

排除标准

  • 1. History of previously diagnosed hereditary coagulation and/or platelet disorders.
  • 2. History of heparin-induced thrombocytopenia
  • 3. Blood sampling for study purposes at less than three time points during the study
  • 4. Participation in other clinical research studies involving evaluation of other investigational
  • drugs or devices within 30 days of randomization
  • 5. Diagnosis of hepatitis B, hepatitis C, and HIV.
  • 6. Age < 18 years

研究者

发起方
niversitätsklinikum Tübingen

相似试验